Suggestions
Stephanie Reed
PhD, Director, Early Stage Formulation Science
Stephanie Reed, Director of Early Stage Formulation Science at AstraZeneca
Stephanie Reed is the Director of Early Stage Formulation Science at AstraZeneca, a global biopharmaceutical company. Based on her LinkedIn profile, she is an R&D leader who nurtures and translates innovations into products using smart science and strategic partnerships.2
AstraZeneca has dedicated business development teams that work with partners to create collaborations that bring value for both parties.1 The company's Pharmaceutical Technology & Development team specifically focuses on partnership opportunities in areas like Product Design & Drug Delivery.1
As an R&D leader at AstraZeneca, Stephanie Reed likely plays a key role in identifying and evaluating early-stage drug candidates and formulations to advance into clinical development. She likely collaborates with cross-functional teams and external partners to progress promising drug candidates through the pipeline.
